Sophia Genetics Sa · NASDAQ:SOPH
Puylaert Kevin sold 624 Sophia Genetics Sa shares (Form 4)
Traded Apr 6, 2026 · Filed Apr 8, 2026
On Apr 6, 2026, Puylaert Kevin (Chief Sales Officer) sold 624 Sophia Genetics Sa shares at an average US$4.86 for US$3,032, leaving 148,230 shares. Filed Apr 8, 2026 (Form 4).
- Sold
- 624 shares
- Price
- US$4.86 average (US$4.83 to US$4.86)
- Value
- US$3,032
- Holding after
- 148,230 shares
- Trading plan
- No
- Role
- Chief Sales Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 6, 2026 | Ordinary Shares | Sale | 548 | US$4.86 | 148,306 | Direct |
| Apr 6, 2026 | Ordinary Shares | Sale | 46 | US$4.86 | 148,260 | Direct |
| Apr 6, 2026 | Ordinary Shares | Sale | 30 | US$4.83 | 148,230 | Direct |
Source
Related
- Sophia Genetics Sa
- Puylaert Kevin
- Sophia Genetics Sa shareholders
- Form 4 · Puylaert Kevin · Oct 7, 2026
- Form 4 · Puylaert Kevin · Jul 7, 2026
- Form 4 · Puylaert Kevin · May 20, 2026
- Form 4 · Puylaert Kevin · Apr 21, 2026
- Form 4/A · Puylaert Kevin · Apr 8, 2026
- Form 4 · Xu Zhenyu · Oct 14, 2026
- Form 4 · Menu Philippe · Oct 14, 2026
- Form 4 · Camblong Jurgi · Oct 14, 2026
- Form 4 · Menu Philippe · Oct 7, 2026
- Form 4 · Valente Manuela · Oct 7, 2026